A home and ambulatory artificial nutrition (NADYA) group report, home parenteral nutrition in Spain, 2013

Wanden-Berghe, C. ; Cristina, Cuerda Compes ; Peláez, R.B. ; Candela, C.G. ; Casas, N.V. ; de, la Cruz ; Villares, J.M.M. ; Pérez, F.C. ; Orbaiz, C.G. ; Faedo, C.M. ; Ángeles, Penacho L. ; Marín, M.G. ; Luna, P.P.G. ; Martín, P.M. ; Sanz Paris, A. ; Pérez, L.M.L. ; Folgueras, T.M. ; Zafra, M.V.G. ; Hernández, Á. ; Martín, C.C. ; Llanos, J.P.S. ; Zugasti, A. ; Celaya, A.A. ; Planella, J.R.U. ; González, L.L. ; Burdiel, O.S.-V ; Ortiz, C.J. ; Costa, C.M. ; Casariego, A.V. ; García, P.L. ; González, M.A.P. ; Carmen, Gil Mart ; Martos, E.Á.S. ; Dolores del, Olmo Garc ; Guardiola, P.D.
A home and ambulatory artificial nutrition (NADYA) group report, home parenteral nutrition in Spain, 2013
Resumen: Aim: to communicate the results of the Spanish Home Parenteral Nutrition (HPN) registry of the NADYA-SENPE group for the year 2013.
Material and methods: data was recorded online by NADYA group collaborators that were responsible of the HPN follow-up from 1st January to 31st December 2013.
Results: a total of 197 patients and 202 episodes of HPN were registered from 35 hospitals that represents a rate of 4,22 patients/million habitants/year 2013. The median age was 53 years (IQR 40 – 64) for 189 adult patients and 7 months (IQR 6 – 35,5) for children. The most frequent disease in adults was neoplasm (30,7%) followed by other diseases (20,1%) and mesenteric ischemia (12,7%). Short bowel syndrome and intestinal obstruction (25,9%) were in 35.7% cases the indications for HPN.

Idioma: Inglés
DOI: 10.3305/nh.2015.31.6.9052
Año: 2015
Publicado en: Nutricion Hospitalaria 31, 6 (2015), 2533-2538
ISSN: 0212-1611

Factor impacto JCR: 1.497 (2015)
Categ. JCR: NUTRITION & DIETETICS rank: 60 / 80 = 0.75 (2015) - Q3 - T3
Factor impacto SCIMAGO: 0.404 - Nutrition and Dietetics (Q3) - Medicine (miscellaneous) (Q3)

Tipo y forma: Article (Published version)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.


Exportado de SIDERAL (2021-01-21-10:57:03)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles



 Record created 2017-09-11, last modified 2021-01-21


Versión publicada:
 PDF
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)